CLINICAL_TRIALS trial_result · 2014-04-15

Clinical Trial Update: Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) [Phase 2]

Phase 2 trial evaluating a selective 5-HT4 receptor agonist with a proton pump inhibitor for GERD has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Shire | Conditions: Gastroesophageal Reflux Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-04-15